Brian Mi, president, Asia Pacific at IQVIA, leads operations in Greater China, Australia, Korea, and eight Southeast Asia countries.
Brian joined IMS Health in 2008, and during his tenure has served in key leadership positions with increasing responsibilities, including senior principal of IMS Consulting Group, general manager of IMS Greater China, president of IMS China and Southeast Asia, and president of IQVIA Greater China.
Prior to IQVIA, Brian held management roles at Pfizer and Amylin Pharmaceuticals, with focus on portfolio planning, new product marketing, R&D strategy and business development.
Brian holds a PhD in pharmaceutical chemistry from Ohio State University and an MBA from the University of Chicago Booth School of Business.
Org chart
Teams
Offices
This person is not in any offices
IQVIA
156 followers
IQVIA, formerly Quintiles IMS Holdings, Inc., is an American multinational company serving the combined industries of health information technologies and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
